Methallenestril

This classification denotes a non-steroidal estrogen with the molecular formula C18H22O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XL025389JS, chemically known as 3-(6-methoxy-2-naphthyl)-3-ethyl-2,2-dimethylpropionsaeure but generally known as methallenestril, which bears US NIH Compound Identifier 10599. European Medicines Agency schedules Methallenestril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08834MIG. The term METHALLENESTRIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules methallenestril in its Anatomical Therapeutic Chemical (ATC) Classification. METHALLENESTRIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, METHALLENESTRIL remains the US FDA Preferred Term for this commodity. Methallenestril bears US NLM identifiers UMLS ID C0066078 and NCI Concept Code C80685. SMILES: OC(=O)C(C(CC)c1cc2c(cc1)cc(OC)cc2)(C)C.